雖然這篇MabThera鄉民發文沒有被收入到精華區：在MabThera這個話題中，我們另外找到其它相關的精選爆讚文章
[爆卦]MabThera是什麼？優點缺點精華區懶人包
你可能也想看看
搜尋相關網站
-
#1MabThera®莫須瘤® - 羅氏
適應症 · Mabthera IV適應症: · 類風濕性關節炎 · 慢性淋巴球性白血病 · 莫須瘤 皮下注射劑 MabThera SC 1400mg.
-
#2【篤實關懷倫理卓越】光田綜合醫院Kuang Tien General Hospital
併用CHOP或其他化學療法用於CD20抗原陽性之B瀰漫性大細胞非何杰金氏淋巴瘤之60歲以上病患。 用法用量. 1. 標準劑量：成年病患使用Mabthera為單一療法時，建議劑量為375 mg/ ...
-
#3莫須瘤
對使用莫. 須瘤靜脈注射劑(MabThera IV)治療之後發生感染的病人，應立即進行評估. 並施以適當的治療。 B型肝炎病毒(HBV)的再活化. 接受CD20導向細胞溶解性抗體類藥物(包含 ...
-
#4類風濕性關節炎患者使用Mabthera，可能發生漸進性多病灶腦 ...
Mabthera 為一單株抗體製劑，本署核定適應症為「1.用於復發或對化學療法有抗性之低惡度B細胞非何杰金氏淋巴瘤。2.併用CVP化學療法用於未經治療之和緩性( ...
-
#5Rituximab - 長庚紀念醫院國際醫療中心
Rituximab，由羅氏Roche藥廠所生產的商品名為MabThera®、莫須瘤®，是一種作用於人類CD20的人鼠嵌合單株抗體。由於CD20主要表現於B淋巴球細胞表面， ...
-
#6Mabthera 莫須瘤注射劑- 藥品查詢系統- 童綜合醫院
商品名稱, Mabthera. 內含量, 500mg/50mL/vial. 學名, Rituximab. 商品外觀. 健保碼, KC00928248, ATC, L01XC02. 許可證, 衛署藥製字5000928. 臨床用途, 化學治療劑。
-
#7Rituximab 莫須瘤® 使用須知 - 奇美醫院
Rituximab 莫須瘤 ® 使用須知. By 藥劑部| April, 2021. 藥號：10R008、10R024. 學名, 中文名, 商品名, 含量, 藥品外觀. Rituximab, 莫須瘤, Mabthera, 100毫克／瓶.
-
#8生物製劑—莫須瘤介紹 - 中亞健康網
目前台灣衛福部核准的莫須瘤(MabThera)適應症，除了B細胞淋巴癌以外尚有：類風溼性關節炎、肉芽腫性血管炎(Granulomatosis with Polyangiitis; GPA)(又名：Wegener's 肉芽 ...
-
#9莫須瘤注射劑 - 華人癌症資訊網
中文名稱：莫須瘤注射劑英文名稱：Rituximab藥品：Mabthera藥品分類：標靶治療藥物仿單適應症：非何杰金氏淋巴瘤：用於復發或對化學療法有抗性之低惡 ...
-
#10【公文】公告異動含rituximab成分藥品（如Mabthera）之支付 ...
【公文】公告異動含rituximab成分藥品（如Mabthera）之支付價格及修訂其藥品給付規定。 由NTPA012 在2020, 十月5 - 15:20 發表.
-
#11－藥品資訊
商品英文名, Mabthera Solution For IV Infusion 500mg/50mL (停用). 商品中文名, 莫須瘤注射劑. 成分名, rituximab 500mg/50ml 連結MICROMEDEX查詢. 劑型, 注射劑.
-
#12抗癌新藥Rituximab - 台灣癌症臨床研究發展基金會
此外CD20抗原亦存在於B-細胞慢性淋巴性白血病之細胞膜上。Rituximab（商品名Mabthera），是一種抗CD20單株抗体，它能與橫跨膜抗原CD2O結合。它在B淋巴細胞 ...
-
#13利妥昔單抗 - 维基百科
利妥昔單抗（通用名，國際非專利藥品名稱：Rituximab，由羅氏Roche藥廠所生產的商品名為Mabthera (全球)、莫須瘤(臺灣)；而由Genentech藥廠所生產的商品名 ...
-
#14用藥指導 - 國軍高雄總醫院
MABTHERA 500MG/50ML△. 商品中文名. 莫須瘤注射劑50ML. 學名. Rituximab. 廠牌. 羅氏大藥廠. 院內碼. IMA5. 健保碼. KC00928248.
-
#15MabThera | European Medicines Agency - europa.eu
MabThera is a medicine used to treat the following blood cancers and inflammatory conditions: ... Depending on the condition it is used to treat, MabThera may be ...
-
#16財團法人醫藥品查驗中心醫療科技評估報告補充資料 - 衛生福利 ...
本申請藥品莫須瘤皮下注射劑(MabThera solution for subcutaneous injection)，主管機關核准適應症為「非何杰金氏淋巴瘤(1)用於復發或對化學療法. 有抗性之低惡度B-細胞非 ...
-
#17MabThera 1400 mg Solution for Subcutaneous Injection - eMC
Before starting MabThera subcutaneous injections, all patients must always receive beforehand, a full dose of MabThera by intravenous infusion, using MabThera ...
-
#18Rituximab (Rituxan & MabThera) - American College of ...
Facts for patients and caregivers about the drug Rituximab (Rituxan, MabThera) such as common usages and dosages, safety tips and side effects.
-
#19認識化療藥品Rituximab SC | 衛教單張
應以皮下注射方式將MabThera SC 注入腹壁，不可施用於紅腫、瘀血、觸痛或堅硬的皮膚表面，或是有痣或疤痕的部位。目前並無注射於身體其他部位的相關資料，故注射部位應侷限 ...
-
#20Comparison of rituximab originator (MabThera ®) to biosimilar ...
The efficacy and safety of the rituximab biosimilar Truxima ® seem equivalent to the originator MabThera ® in MS patients. Truxima ® could represent a ...
-
#21MABT2 - 藥品資料
可接受MabThera IV全劑量輸注的患者，在第二劑或後續給藥可以MabThera SC皮下注射治療。 副作用(藥袋列印)：, 過敏反應、注射反應(發燒、噁心、寒顫、嘔吐等).
-
#22MABTHERA INJ 10 MG/ML 10 ML 莫須瘤注射劑 - 國立陽明 ...
中文品名：莫須瘤注射劑. 英文品名：MABTHERA 100 MG/ML 10 ML INJ. 成分學名：rituximab. 藥品許可證字號：衛署菌疫輸字第000928號.
-
#23長庚兒童過敏氣喘風濕科-常用藥品Mabthera
藥名: Mabthera 莫須瘤 學名: Rituximab(ivf) 100mg/10ml/vial. 適用: 頑固類風濕性關節炎及紅斑性狼瘡抗CD20單株抗体. 副作用: 噁心；嘔吐；眩暈；頭痛；淋巴球低下； ...
-
#24全民健康保險藥物給付項目及支付標準
Mabthera )： (91/4/1、93/1/1、. 95/3/1、97/2/1、102/1/1、. 103/2/1、103/9/1). 限用於. 1. 復發或對化學療效有抗性之低惡度B. 細胞非何杰金氏淋巴瘤。(91/4/1).
-
#25Mabthera - Healthdirect Australia
Rheumatoid Arthritis: MABTHERA (rituximab) in combination with methotrexate is indicated for the treatment of adult patients with severe, active rheumatoid ...
-
#26Rituximab (Mabthera®)利妥昔單抗檢測試劑盒 - 太鼎生物科技
Rituximab (Mabthera®)利妥昔單抗ELISA Kit檢測試劑盒(競爭型酶聯免疫吸附試驗法) |貨號K4257-100 在人血清和血漿中Rituximab (Mabthera®)利妥昔單抗的定量測量。
-
#27衛部菌疫輸字第001022號 - 藥物許可證查詢
2.慢性淋巴球性白血病(1)莫須瘤(MabThera)適用於與fludarabine及cyclophosphamide併用，做為CD20陽性慢性淋巴球性白血病(CLL)患者的第一線用藥。 (2)莫須瘤(MabThera)適用 ...
-
#28公告暫予支付含rituximab成分藥品之皮下注射劑MabThera ...
修正後給付規定. 原給付規定. 8.2.7.Rituximab注射劑（如Mabthera，不同劑型之適用範圍需符合藥品許可證登載之適應症)：用於類風濕性關節炎之成人治療 ...
-
#29Mabthera (NHL/CLL) (rituximab) Drug / Medicine Information
MabThera is available as a clear, colourless, concentrated solution for intravenous infusion. It is diluted before infusion into a vein. Ingredients. MabThera ...
-
#30Rituximab (Mabthera) | Cancer information - Cancer Research ...
Rituximab is a targeted cancer drug and is also known by its brand names MabThera, Rixathon and Truxima. It is a treatment for: ... You might have the original ...
-
#31MABTHERA® - Medsafe
MABTHERA ®. Non-Hodgkin's Lymphoma and. Chronic Lymphocytic Leukaemia. Rituximab. 100 mg in 10 mL and 500 mg in 50 mL concentrate for solution for infusion.
-
#32Evaluate the Efficacy and Safety of HLX01 Versus Mabthera in ...
Evaluate the Efficacy and Safety of HLX01 Versus Mabthera in Patients With Low Tumour Burden Follicular Lymphoma.
-
#33MabThera: Uses, Side Effects, Benefits/Risks | Drugs.com
What is MabThera and what is it used for? ... MabThera is a medicine used to treat the following blood cancers and inflammatory conditions: ... Depending on the ...
-
#34MabThera IV Full Prescribing Information, Dosage & Side Effects
MabThera IV(rituximab): Non-Hodgkin's Lymphoma: MabThera is indicated for the treatment of: patients with relapsed or chemoresistant low-grade or follicula.
-
#35MabThera | Roche Australia
Pharmaceutical Product Information. MabThera® (rituximab) solution for IV infusion. Patients. NHL/CLL Consumer Medicine Information (CMI) ...
-
#36MabThera «Roche» - Felleskatalogen
MabThera, og hos pasienter refraktære overfor tidligere behandling med MabThera pluss kjemoterapi. Konsentrat til infusjonsvæske: Non-Hodgkins lymfom (NHL) ...
-
#37MabThera (rituximab) Update - Lymphoma Australia
From 1 April 2021, Roche will be removing MabThera IV from the Pharmaceutical Benefits Scheme (PBS). Whilst subsidised access to Roche ...
-
#38MabThera 500 mg concentrate for solution for infusion
MabThera contains an antibody (rituximab) which is a type of protein. Rituximab binds to the surface of a type of white blood cell, the B lymphocyte.
-
#39PROSPECTO MABTHERA 500 MG CONCENTRADO ... - CIMA
MabThera se utiliza en el tratamiento de la artritis reumatoide en personas que ya hayan sido tratadas con otros medicamentos, que bien han dejado de funcionar ...
-
#40MABTHERA - Orphanet
MABTHERA. Rituximab. Marketing authorization without orphan designation - Europe. Diseases list. Follicular lymphoma; Microscopic polyangiitis; Diffuse large B ...
-
#41MABTHERA (rituximab) - Haute Autorité de Santé
The clinical benefit of MABTHERA is substantial in the treatment of patients with moderate to severe pemphigus vulgaris (PV).
-
#42認識標靶藥品Rituximab | 衛教單張 - 中國醫藥大學附設醫院
Mabthera ® ；莫須瘤注射劑。 藥物簡介. 屬抗癌單株抗體藥物，可單獨使用或與其他藥物合併使用於B細胞淋巴瘤，類風溼性關節炎或復發的CD20陽性慢性淋巴性白血病，或依 ...
-
#43MabThera SC Subcutaneous Injection - NPS MedicineWise
MabThera SC helps many people who have non-Hodgkin's lymphoma or chronic lymphocytic leukaemia but it may have unwanted side effects. All medicines can have ...
-
#44新一代生物製劑-莫須瘤 - 陳英州(陳璿達)醫師
MabThera ®是以裝有50 mL藥液(含500 mg MabThera®，10 mg/mL)a的單次使用、無防腐劑、透明第I類玻璃、有丁基橡膠(butyl rubber)瓶塞的藥瓶供應。
-
#45Mabthera®, Ritemvia, Rixathon (rituximab) - Svar Life Science
Mabthera ®, Ritemvia, Rixathon (rituximab) ... Binding of rituximab to CD20 causes death of B-lymphocytes. Rituximab binds specifically to the transmembrane ...
-
#46MabThera and Tarceva removed from PBS
medicines, MabThera® IV (rituximab) solution for intravenous injection and Tarceva® (erlotinib). From 1 April 2021, we will be removing ...
-
#47MABTHERA 100 MG INJECTION: View Uses, Side ... - 1MG
MABTHERA 100 MG INJECTION is used in the treatment of Non-Hodgkin lymphoma (NHL),Rheumatoid arthritis,Blood cancer (Chronic lymphocytic ...
-
#48Randomized, Double-Blind, Pharmacokinetic Equivalence ...
PURPOSEWe sought to compare the pharmacokinetics (PKs) of DRL-rituximab (DRL_RI; potential biosimilar) and innovator rituximab MabThera ...
-
#49MabThera | Roche Non-Hodgkins Lymphoma Treatment
MabThera ®. (rituximab). Pronounced Mab-there-rah. MabThera, also known as rituximab, is a prescription medicine ...
-
#50A Study of GDC-0199 (ABT-199) Plus MabThera/Rituxan ...
This open-label, randomized study will compare the efficacy of GDC-0199 plus rituximab (GDC-0199+R) with bendamustine plus MabThera/Rituxan (Rituximab) (B+R) in ...
-
#51MABTHERA, 500MG INF CNC SOL 1X50ML, Státní ústav pro ...
Rituximab je hrazen: 1) v léčbě folikulárního lymfomu III. a IV. klinického stadia nebo u rizikových nemocných II. klinického stádia (dle GELF kritérií), kde je ...
-
#52Single Centre UK Comparison of Biosimilar Rituximab ...
45 patients were treated with MabThera and 39 with the rituximab biosimilar Truxima. Laboratory parameters recorded included the patient's platelet counts, ...
-
#53MabThera® 1400 mg solution for subcutaneous injection ...
MabThera SC is indicated in adults for non-Hodgkin's lymphoma (NHL) only: • for the treatment of previously untreated patients with.
-
#54MabThera 100 mg and 500 mg concentrate for solution for ...
MabThera 100 mg and 500 mg concentrate for solution for infusion *. Company: Roche Registration GmbH. Status: No Recent Update ...
-
#55RITUXIMAB | Medicinal forms | BNF content published by NICE
MabThera 100mg/10ml concentrate for solution for infusion vials (Roche Products Ltd). Active ingredients, Size, Unit, NHS indicative price, Drug tariff ...
-
#56rituximab subcutaneous (Mabthera) - Scottish Medicines ...
rituximab subcutaneous injection (Mabthera®) is accepted for restricted use within NHS Scotland. Indication under review: for non-Hodgkin's ...
-
#57臺北市立聯合醫院藥品異動通知
Mabthera solution for Infusion. 中文商品名稱. 莫須瘤注射劑(德國廠). 許可證字號. 衛署菌疫輸字第000928 號. 健保代碼. K000928229. 廠牌名稱.
-
#58Roche's new time-saving subcutaneous formulation of ...
Roche's new time-saving subcutaneous formulation of MabThera approved in Europe for the treatment of common forms of non-Hodgkin Lymphoma ...
-
#59mabthera - Chinese translation – Linguee
Mabthera ／Rituximab乃常用於治療所有B細胞淋巴瘤的單克隆抗體， 而I matin ib 則是一種能有效治療慢性骨髓性白血病的化療藥物。 hksh.com.
-
#60Pfizer wins EU approval for MabThera biosimilar - PharmaTimes
Pfizer has bagged European approval for Ruxience (rituximab), a monoclonal antibody (mAb) and biosimilar to MabThera (rituximab).
-
#61MabThera (rituximab (rch)) information | myVMC
MabThera is used to treat rheumatoid arthritis (RA), Granulomatosis with polyangiitis (formerly known as Wegener's granulomatosis) (GPA) and Microscopic ...
-
#62Attachment 1. Product information for Mabthera - TGA
two infusions of MABTHERA and remained at that level in most patients through month 6. Pharmacokinetics. Non-Hodgkin's Lymphoma.
-
#63Comparison of Rituximab originator (MabThera) to biosimilar ...
Comparison of Rituximab originator (MabThera) to biosimilar (Truxima) in patients with immune-mediated thrombotic thrombocytopenic purpura.
-
#64098.12.29 健保審字第0980095880 號修正「全民健康保險藥品 ...
8.2.7.rituximab 注射劑（如Mabthera）」給付規定，並自中華民國九十九年二月一. 日生效。 附修正「全民健康保險藥品給付規定—第8 章免疫製劑Immunologic agents.
-
#65To Determine The Financial Imapct of Introducing Sc ...
Currently used iv rituximab (MABTHERA) on The Budgets of Different Hospitals Across The Kingdom of Saudi Arabia (KSA). Rauf M.
-
#66MabThera_百度百科
利妥昔单抗是一种嵌合鼠/人的单克隆抗体，该抗体与纵贯细胞膜的CD20抗原特异性结合。此抗原位于前B和成熟B淋巴细胞，但在造血干细胞，后B细胞，正常血浆细胞， ...
-
#67Search for MabThera (rituximab) - EU Clinical Trials Register
Clinical trials for MabThera (rituximab). The European Union Clinical Trials Register allows you to search for protocol and results information on:
-
#68BioSim™ anti-Rituximab (Mabthera®) (Human) ELISA Kit
BioSim™ anti-Rituximab (Mabthera®) (Human) ELISA Kit. A Sandwich ELISA kit for the quantitative measurement of antibody against Rituximab in human serum or ...
-
#69MabThera Injection - IndiaMART
Find here MabThera Injection, MabThera dealers, retailers, stores & distributors. Get latest prices, models & wholesale prices for buying MabThera ...
-
#70Scandinavian Journal of Rheumatology - Taylor & Francis ...
Comparison of outcomes using the rituximab originator MabThera with the biosimilar Truxima in patients with ANCA-associated vasculitis.
-
#71Rituxan/MabThera (rituximab) - News, Articles etc. - European ...
News stories and articles referencing Rituxan/MabThera (rituximab) on European Pharmaceutical Review.
-
#72Roche's Subcutaneous MabThera Approved in Europe
Swiss drugmaker Roche said that European regulators have approved a new timesaving formulation of its blood cancer drug MabThera (rituximab) ...
-
#73Comparison of rituximab originator (MabThera ® ) to ...
Conclusion The efficacy and safety of the rituximab biosimilar Truxima ® seem equivalent to the originator MabThera ® in MS patients. Truxima ® could represent ...
-
#74Rituximab (Mabthera° or other brands) in pemphigus vulgaris
Rituximab (Mabthera° or other brands) in pemphigus vulgaris: more patients in remission than with other immunosuppressants, lower exposure ...
-
#75MabThera: Bula original, extraída manualmente da Anvisa | CR
MabThera ® em combinação com metotrexato está indicado para o tratamento de pacientes adultos com artrite reumatoide ativa que tiveram resposta inadequada ou ...
-
#76Comparative Nonclinical Assessments of the ... - SAGE Journals
Comparative nonclinical studies were conducted with the proposed biosimilar PF-05280586 and rituximab-EU (MabThera®).
-
#77Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma
Citation: Knight C, Hind D, Brewer N, Abbott V. Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma: a systematic review and economic evaluation.
-
#78Subcutaneous administration of rituximab (MabThera) and ...
Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase. O Shpilberg &; C Jackisch.
-
#79MABTHERA ® - Foglietto Illustrativo - My Personal Trainer
MabThera è utilizzato per trattare l'artrite reumatoide in persone che hanno già provato altri medicinali, che però hanno smesso di funzionare, non hanno ...
-
#80EMA Approves Roche's MabThera SC For Non-Hodgkin ...
Roche recently announced it has secured approval from the European Commission for the new subcutaneous formulation of MabThera (rituximab) ...
-
#81Mabthera 500 mg c1 frasco ámpula 50ml - Farmacia San Pablo
Rituximab 500 MG: Item: 30170007: UPC: 7613326005661. Ficha técnica: Con el servicio 24 hrs de Farmacia San Pablo puedes comprar Mabthera ...
-
#82Rituximab (MabThera) Drug Information - Understanding ...
MabThera is approved for: Patients with stage 3-4 follicular B-cell Non-Hodgkin lymphoma whose cancer did not respond to previous treatment with ...
-
#83Mabthera (Rituximab) Wholesaler, Distributor - Rasso Swiss ...
MABTHERA /RITUXAN (RITUXIMAB) DESCRIPTION: Rituximab is the first therapeutic monoclonal antibody to target cells that have the CD20 marker on their surface.
-
#84Mabthera 1400 mg / 11.7 ml ( Rituximab ) Solution for ...
MabThera 1400 mg / 11.7 ml ( Rituximab ) Solution for Subcutaneous Injection Vial. Package leaflet: Information for the patient. MabThera 1400 mg solution ...
-
#85Mabthera (Rituximab) - South Delhi Pharma
MabThera is approved for the treatment of adults with the following blood cancers: previously untreated and relapsed or refractory follicular lymphoma, ...
-
#86MabThera (Rituximabe) é coberto pelo plano de saúde
O medicamento MabThera (Rituximabe) deve ser coberto pelo plano de saúde sempre que houver indicação médica e a negativa é considerada abusiva.
-
#87MABTHERA - Medicamentos PLM
Marca. MABTHERA. Sustancias. RITUXIMAB. Forma Farmacéutica y Formulación. Concentrado para solución de infusión. Presentación.
-
#88MabThera 500mg/50mL | Farmacias Especializadas | FESA
MabThera 500mg/50mL. 1 ampula. Rituximab. Laboratorio Roche. Compra medicamentos de alta especialidad en oncologia con entrega a domicilio.
-
#89Mabthera 500mg Vial - Rosheta
Mabthera 500mg. Scientific Name: Rituximab 500mg. Drag Period: Type: Vial; Producing Company: U.K. company. This Medicine is not available.
-
#90Precio Mabthera 100 mg 2 frascos ámpula de 10 mL
Precio Mabthera 100 mg 2 frascos ámpula de 10 mL en Farmalisto MX. Entregas a domicilio en CDMX y el interior de la República Mexicana.
-
#91¿Qué es MabThera? » Su Definición y Significado [2021]
MabThera es el nombre comercial del principio activo rituximab. Es un anticuerpo monoclonal empleado en el tratamiento de diferentes tipos de leucemia y ...
-
#92Mabthera 100MG/ 10ML caja con 2 viales - Audifarma ...
- mabthera® en combinación con chop para tratamiento de pacientes con linfomas con células b grandes. Nombre: Mabthera. Laboratorio: PRODUCTOS ROCHE S.A..
-
#93Roche to present new pivotal data at ASH 2021 from broad ...
POLARIX met its primary endpoint of improving progression-free survival, showing Polivy® (polatuzumab vedotin) plus MabThera®/Rituxan® ...
-
#94mabthera 100 mg / 10 ml 2 vial
MabThera (Rituximab) 100 mg/10 ml 2 vials of 10 ml of concentrate for solution for infusion. * 1 vial = 100 mg rituximab. also, Sodium chloride, ...
-
#95MABTHERA 100MG INJECTION, Roche - 98.4 Online
MABTHERA 100 MG INJECTION is used in the treatment of non-Hodgkin lymphoma (NHL), blood cancer (Chronic lymphocytic leukemia) and rheumatoid arthritis.
-
#96Mabthera 500 mg/50ml 1 vial® - Ixirix.com
Therapeutic properties of Mabthera 500 mg: It used in the treatment of Non-Hodgkin's lymphoma. Product used in chronic lymphocytic leukemia's treatment.
mabthera 在 コバにゃんチャンネル Youtube 的精選貼文
mabthera 在 大象中醫 Youtube 的精選貼文
mabthera 在 大象中醫 Youtube 的最佳解答